Nutritional and cosmetic ingredient developer Sabinsa Corp. is turning to US regulatory agencies to pick up its hunt for dietary and food ingredients falsely labeled or advertised as vitamin C equivalents.
Sabinsa on 30 November announced it has provided the Food and Drug Administration and the Federal Trade Commission with documentation...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?